Menu
GeneBe

SPINT3

serine peptidase inhibitor, Kunitz type 3

Basic information

Region (hg38): 20:45512460-45515622

Links

ENSG00000101446NCBI:10816OMIM:613941HGNC:11248Uniprot:P49223AlphaFoldGenCCjaxSfariGnomADPubmedClinVar

Phenotypes

GenCC

Source: genCC

No genCC data.

ClinVar

This is a list of variants' phenotypes submitted to ClinVar and linked to the SPINT3 gene.

  • Inborn genetic diseases (5 variants)
  • Bladder exstrophy-epispadias-cloacal extrophy complex (1 variants)

Variants pathogenicity by type

Statistics on ClinVar variants can assist in determining whether a specific variant type in the SPINT3 gene is commonly pathogenic or not.

In the table, we include only reliable ClinVar variants with their consequences to MANE Select, Mane Plus Clinical transcripts, or transcripts with TSL equals 1. Click the count to view the source variants.

Warning: slight differences between displayed counts and the number of variants in ClinVar may occur, primarily due to (1) the application of a different transcript and/or consequence by our variant effect predictor or (2) differences in clinical significance: we classify Benign/Likely benign variants as Likely benign and Pathogenic/Likely pathogenic variants as Likely pathogenic.

Variant type Pathogenic Likely pathogenic VUS Likely benign Benign Sum
synonymous
0
missense
6
clinvar
6
nonsense
0
start loss
0
frameshift
0
inframe indel
0
splice donor/acceptor (+/-2bp)
0
splice region
0
non coding
0
Total 0 0 6 0 0

Variants in SPINT3

This is a list of pathogenic ClinVar variants found in the SPINT3 region.

You can filter this list by clicking the number of variants in the Variants pathogenicity by type table.

Position Type Phenotype Significance ClinVar
20-45512655-G-T not specified Uncertain significance (Jan 22, 2024)3169183
20-45512740-A-G not specified Uncertain significance (Dec 19, 2023)3169182
20-45512757-T-C not specified Uncertain significance (Sep 16, 2021)2250426
20-45512772-G-A Bladder exstrophy-epispadias-cloacal extrophy complex Uncertain significance (-)2627996
20-45512795-C-G not specified Uncertain significance (Jan 04, 2022)2217586
20-45512803-T-C not specified Uncertain significance (Oct 25, 2022)2341923
20-45512812-C-T not specified Uncertain significance (Dec 22, 2023)3169181
20-45515550-C-T not specified Uncertain significance (Sep 29, 2022)3169184
20-45515556-T-G not specified Uncertain significance (May 24, 2023)2519132
20-45515578-G-C not specified Uncertain significance (Jun 27, 2022)2350730

GnomAD

Source: gnomAD

GeneTypeBio TypeTranscript Coding Exons Length
SPINT3protein_codingprotein_codingENST00000217428 23164
pLI Probability
LOF Intolerant
pRec Probability
LOF Recessive
Individuals with
no LOFs
Individuals with
Homozygous LOFs
Individuals with
Heterozygous LOFs
Defined p
0.01730.49800000.00
Z-Score Observed Expected Observed/Expected Mutation Rate Total Possible in Transcript
Missense0.4253947.20.8260.00000261575
Missense in Polyphen815.6490.51123188
Synonymous1.60917.50.5140.00000102161
Loss of Function-0.48521.381.445.93e-815

LoF frequencies by population

EthnicitySum of pLOFs p
African & African-American0.000.00
Ashkenazi Jewish0.000.00
East Asian0.000.00
Finnish0.000.00
European (Non-Finnish)0.000.00
Middle Eastern0.000.00
South Asian0.000.00
Other0.000.00

dbNSFP

Source: dbNSFP

Intolerance Scores

loftool
rvis_EVS
0.66
rvis_percentile_EVS
84.27

Haploinsufficiency Scores

pHI
0.000300
hipred
hipred_score
ghis

Essentials

essential_gene_CRISPR
N
essential_gene_CRISPR2
N
essential_gene_gene_trap
N
gene_indispensability_pred
N
gene_indispensability_score
0.120

Gene Damage Prediction

AllRecessiveDominant
MendelianMediumMediumMedium
Primary ImmunodeficiencyMediumMediumMedium
CancerMediumMediumMedium

Mouse Genome Informatics

Gene name
Spint3
Phenotype

Gene ontology

Biological process
negative regulation of endopeptidase activity;negative regulation of transforming growth factor beta receptor signaling pathway;extracellular negative regulation of signal transduction
Cellular component
extracellular region
Molecular function
serine-type endopeptidase inhibitor activity;receptor antagonist activity;transforming growth factor beta binding